We are live on ! Find out more
PWM

Palumbo Wealth Management Portfolio holdings

AUM $478M
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+1.61%
1 Year Est. Return
+50.95%
3 Year Est. Return
+115.15%
5 Year Est. Return
+128.51%
10 Year Est. Return
AUM
$410M
AUM Growth
+$4.51M
Cap. Flow
+$12.8M
Cap. Flow %
3.12%
Top 10 Hldgs %
40.38%
Holding
241
New
23
Increased
104
Reduced
76
Closed
20

Sector Composition

Rank Sector Weight
1 Technology 16.45%
2 Healthcare 9.8%
3 Consumer Discretionary 8.46%
4 Industrials 7.3%
5 Communication Services 7.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOM icon
76
ExxonMobil
XOM
$658B
$931K 0.23%
5,489
+55
+1% +$8.03K
WMT icon
77
Walmart Inc
WMT
$917B
$918K 0.22%
7,390
+57
+0.8% +$7K
PMAY icon
78
Innovator US Equity Power Buffer ETF May
PMAY
$820M
$915K 0.22%
22,880
+4,526
+25% +$180K
VLO icon
79
Valero Energy
VLO
$98.4B
$870K 0.21%
3,522
+45
+1% +$9.28K
DNTH icon
80
Dianthus Therapeutics
DNTH
$6.49B
$869K 0.21%
10,360
-4,607
-31% -$267K
SNDX icon
81
Syndax Pharmaceuticals
SNDX
$1.77B
$869K 0.21%
37,183
-14,185
-28% -$308K
CVX icon
82
Chevron
CVX
$392B
$829K 0.2%
4,005
+237
+6% +$43.2K
BALT icon
83
Innovator Defined Wealth Shield ETF
BALT
$2.8B
$786K 0.19%
23,478
-18,110
-44% -$609K
RECS icon
84
Columbia Research Enhanced Core ETF
RECS
$6.1B
$784K 0.19%
20,104
IDYA icon
85
IDEAYA Biosciences
IDYA
$3.49B
$763K 0.19%
22,888
-5,136
-18% -$172K
DSGN icon
86
Design Therapeutics
DSGN
$928M
$760K 0.19%
71,408
+2,031
+3% +$20.6K
HON icon
87
Honeywell
HON
$74.2B
$751K 0.18%
3,325
+137
+4% +$31.3K
NVAX icon
88
Novavax
NVAX
$1.33B
$750K 0.18%
+92,111
New +$835K
NKTR icon
89
Nektar Therapeutics
NKTR
$2.47B
$732K 0.18%
10,173
-4,541
-31% -$259K
XMTR icon
90
Xometry
XMTR
$5.52B
$727K 0.18%
17,800
+1,683
+10% +$89.4K
DFTX
91
Definium Therapeutics
DFTX
$5.73B
$718K 0.18%
37,966
-1,036
-3% -$17.6K
IMNM icon
92
Immunome
IMNM
$3.09B
$701K 0.17%
32,051
+1,073
+3% +$23.9K
VTI icon
93
Vanguard Morningstar Total Stock Market ETF
VTI
$695B
$697K 0.17%
2,173
-34
-2% -$11.4K
EVMN
94
Evommune Inc
EVMN
$532M
$688K 0.17%
+29,931
New +$677K
SSO icon
95
ProShares Ultra S&P500
SSO
$8.47B
$687K 0.17%
13,240
+17
+0.1% +$972
MTUM icon
96
iShares MSCI USA Momentum Factor ETF
MTUM
$26.2B
$685K 0.17%
2,852
MLPX icon
97
Global X MLP & Energy Infrastructure ETF
MLPX
$3.62B
$672K 0.16%
9,082
EBS icon
98
Emergent Biosolutions
EBS
$235M
$666K 0.16%
80,264
-36,857
-31% -$382K
TSHA icon
99
Taysha Gene Therapies
TSHA
$1.9B
$656K 0.16%
146,709
-31,298
-18% -$146K
NEE icon
100
NextEra Energy
NEE
$180B
$655K 0.16%
7,049
+473
+7% +$42.1K

Similar funds

Palumbo Wealth Management's Q1 2026 Portfolio in Review

As of Q1 2026, Palumbo Wealth Management held 241 positions worth $410M, up 1.1% from $405M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Palumbo Wealth Management deployed $12.8M of net new capital in Q1 2026, opening 23 new positions and adding to 104 existing holdings. Its largest new stake was Invesco S&P 500 Equal Weight ETF: 6,208 shares worth $1.19M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Williams-Sonoma, an estimated $2.47M trimmed.

  • Palumbo Wealth Management's largest Q1 2026 buy was Invesco S&P 500 Equal Weight ETF: 6,208 shares worth $1.19M.
  • Palumbo Wealth Management added most to JPMorgan Chase in Q1 2026, an estimated $5.47M increase.
  • Palumbo Wealth Management's biggest Q1 2026 reduction was Williams-Sonoma, cutting an estimated $2.47M.
  • Palumbo Wealth Management fully exited Grayscale Bitcoin Trust in Q1 2026, selling an estimated $4.6M.
  • Palumbo Wealth Management's ten largest holdings make up 40% of its $410M portfolio in Q1 2026.
  • Palumbo Wealth Management opened 23 new positions and closed 20 in Q1 2026.
  • Palumbo Wealth Management's portfolio value rose 1.1% quarter-over-quarter to $410M.

Based on Palumbo Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.